HSDT HSDT

Helius Medical Technolog... Stock Price

0.569
0.029 (5.37%)
Upgrade to Real-Time
Afterhours (Closed)
0.569
Volume 7,553,889
Bid Price 0.565
Ask Price 0.98
News -
Day High 0.595

Low
0.451

52 Week Range

High
15.69

Day Low 0.5305
Company Name Stock Ticker Symbol Market Type
Helius Medical Technologies Inc HSDT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.029 5.37% 0.569 00:00:11
Open Price Low Price High Price Close Price Prev Close
0.5853 0.5305 0.595 0.55 0.54
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,461 7,553,889 $ 0.5606343 $ 4,234,969 - 0.451 - 15.69
Last Trade Time Type Quantity Stock Price Currency
19:58:55 formt 1,600 $ 0.569 USD

Period:

Draw Mode:

Helius Medical Technologies Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.16M 3.80M 3.42M $ 522.00k $ - -7.33 -0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 322.62k 23.10%

more financials information »

Helius Medical Technolog... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HSDT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.49520.5950.4510.493053511,595,3100.073814.9%
1 Month1.102.760.4510.93226185,389,008-0.531-48.27%
3 Months1.512.760.4511.283,028,018-0.941-62.32%
6 Months4.064.760.4511.291,403,967-3.49-85.99%
1 Year15.6915.690.4511.44704,004-15.12-96.37%
3 Years71.7576.1250.45111.31472,286-71.18-99.21%
5 Years250.25462.000.45128.39358,928-249.68-99.77%

Helius Medical Technolog... Description

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources.


Your Recent History
NASDAQ
HSDT
Helius Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now